MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ROIV
3. ANET
4. NKE
5. PANW
6. CL
7. SNDK
8. TAP
9. DELL
10. EAT

Go back to MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab
MACROGENICS (NASDAQ: MGNX) Delayed: 4.40 +0.15 (3.53%)
Previous Close $4.25    52 Week High $36.11 
Open $4.20    52 Week Low $14.84 
Day High $4.49    P/E 11.28 
Day Low $4.18    EPS $0.39 
Volume 442,786